vs
VAALCO ENERGY INC（EGY）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
VAALCO ENERGY INC的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$91.0M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -64.4%，领先448.4%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -25.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -4.7%）
VAALCO能源是一家从事油气勘探开发的能源企业，公司注册于美国特拉华州，总部位于德克萨斯州休斯顿，核心业务区块位于加蓬近海的埃塔姆马林区块。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
EGY vs RIGL — 直观对比
营收规模更大
EGY
是对方的1.3倍
$69.8M
营收增速更快
RIGL
高出46.4%
-25.2%
净利率更高
RIGL
高出448.4%
-64.4%
两年增速更快
RIGL
近两年复合增速
-4.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $91.0M | $69.8M |
| 净利润 | $-58.6M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -71.3% | 33.2% |
| 净利率 | -64.4% | 384.0% |
| 营收同比 | -25.2% | 21.2% |
| 净利润同比 | -602.5% | 1769.2% |
| 每股收益（稀释后） | $-0.56 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EGYRIGL
| Q4 25 | $91.0M | $69.8M | ||
| Q3 25 | $61.0M | $69.5M | ||
| Q2 25 | $96.9M | $101.7M | ||
| Q1 25 | $110.3M | $53.3M | ||
| Q4 24 | $121.7M | $57.6M | ||
| Q3 24 | $140.3M | $55.3M | ||
| Q2 24 | $116.8M | $36.8M | ||
| Q1 24 | $100.2M | $29.5M |
净利润EGYRIGL
| Q4 25 | $-58.6M | $268.1M | ||
| Q3 25 | $1.1M | $27.9M | ||
| Q2 25 | $8.4M | $59.6M | ||
| Q1 25 | $7.7M | $11.4M | ||
| Q4 24 | $11.7M | $14.3M | ||
| Q3 24 | $11.0M | $12.4M | ||
| Q2 24 | $28.2M | $-1.0M | ||
| Q1 24 | $7.7M | $-8.2M |
毛利率EGYRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率EGYRIGL
| Q4 25 | -71.3% | 33.2% | ||
| Q3 25 | 1.5% | 40.9% | ||
| Q2 25 | 17.7% | 60.1% | ||
| Q1 25 | 23.7% | 23.9% | ||
| Q4 24 | 32.7% | 28.9% | ||
| Q3 24 | 31.4% | 25.4% | ||
| Q2 24 | 17.5% | 1.2% | ||
| Q1 24 | 32.1% | -23.6% |
净利率EGYRIGL
| Q4 25 | -64.4% | 384.0% | ||
| Q3 25 | 1.8% | 40.2% | ||
| Q2 25 | 8.6% | 58.6% | ||
| Q1 25 | 7.0% | 21.5% | ||
| Q4 24 | 9.6% | 24.9% | ||
| Q3 24 | 7.8% | 22.5% | ||
| Q2 24 | 24.1% | -2.8% | ||
| Q1 24 | 7.7% | -27.9% |
每股收益（稀释后）EGYRIGL
| Q4 25 | $-0.56 | $14.11 | ||
| Q3 25 | $0.01 | $1.46 | ||
| Q2 25 | $0.08 | $3.28 | ||
| Q1 25 | $0.07 | $0.63 | ||
| Q4 24 | $0.12 | $0.82 | ||
| Q3 24 | $0.10 | $0.70 | ||
| Q2 24 | $0.27 | $-0.06 | ||
| Q1 24 | $0.07 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $58.9M | $155.0M |
| 总债务越低越好 | $60.0M | $52.5M |
| 股东权益账面价值 | $443.5M | $391.5M |
| 总资产 | $913.4M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.14× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资EGYRIGL
| Q4 25 | $58.9M | $155.0M | ||
| Q3 25 | $24.0M | $137.1M | ||
| Q2 25 | $67.9M | $108.4M | ||
| Q1 25 | $40.9M | $77.1M | ||
| Q4 24 | $82.7M | $77.3M | ||
| Q3 24 | $89.1M | $61.1M | ||
| Q2 24 | $62.9M | $49.1M | ||
| Q1 24 | $113.3M | $49.5M |
总债务EGYRIGL
| Q4 25 | $60.0M | $52.5M | ||
| Q3 25 | $60.0M | $60.0M | ||
| Q2 25 | $60.0M | $60.0M | ||
| Q1 25 | $0 | $60.0M | ||
| Q4 24 | $0 | $60.0M | ||
| Q3 24 | $0 | $60.0M | ||
| Q2 24 | $0 | $60.0M | ||
| Q1 24 | $0 | $60.0M |
股东权益EGYRIGL
| Q4 25 | $443.5M | $391.5M | ||
| Q3 25 | $505.9M | $117.6M | ||
| Q2 25 | $511.6M | $81.9M | ||
| Q1 25 | $504.1M | $18.6M | ||
| Q4 24 | $501.6M | $3.3M | ||
| Q3 24 | $501.0M | $-14.6M | ||
| Q2 24 | $493.6M | $-29.9M | ||
| Q1 24 | $472.6M | $-31.7M |
总资产EGYRIGL
| Q4 25 | $913.4M | $513.6M | ||
| Q3 25 | $950.4M | $242.5M | ||
| Q2 25 | $964.9M | $206.7M | ||
| Q1 25 | $927.1M | $176.0M | ||
| Q4 24 | $955.0M | $164.0M | ||
| Q3 24 | $937.9M | $139.4M | ||
| Q2 24 | $917.4M | $128.4M | ||
| Q1 24 | $809.1M | $126.5M |
负债/权益比EGYRIGL
| Q4 25 | 0.14× | 0.13× | ||
| Q3 25 | 0.12× | 0.51× | ||
| Q2 25 | 0.12× | 0.73× | ||
| Q1 25 | 0.00× | 3.23× | ||
| Q4 24 | 0.00× | 18.25× | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $145.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EGYRIGL
| Q4 25 | $145.2M | $22.0M | ||
| Q3 25 | $16.4M | $24.0M | ||
| Q2 25 | $18.3M | $30.5M | ||
| Q1 25 | $32.7M | $-893.0K | ||
| Q4 24 | $44.5M | $14.5M | ||
| Q3 24 | $47.8M | $21.7M | ||
| Q2 24 | $-438.0K | $302.0K | ||
| Q1 24 | $21.8M | $-5.0M |
自由现金流EGYRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $29.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率EGYRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 26.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度EGYRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率EGYRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 14.94× | 0.86× | ||
| Q2 25 | 2.19× | 0.51× | ||
| Q1 25 | 4.23× | -0.08× | ||
| Q4 24 | 3.82× | 1.01× | ||
| Q3 24 | 4.35× | 1.75× | ||
| Q2 24 | -0.02× | — | ||
| Q1 24 | 2.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EGY
| Crude Oil Sales And Purchase Agreements | $54.8M | 60% |
| Other | $31.9M | 35% |
| Crude Oil | $3.0M | 3% |
| Natural Gas Liquids Reserves | $1.4M | 2% |
RIGL
暂无分部数据
